{
    "2021-04-09": [
        [
            {
                "time": "",
                "original_text": "超1/5跳槽，薪水相差百倍，二八分化下的无力和焦虑……2020年董秘市值管理压力剧增",
                "features": {
                    "keywords": [
                        "跳槽",
                        "薪水",
                        "二八分化",
                        "董秘",
                        "市值管理"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "【光大金工|基金研究】华夏基金蔡向阳：坚持价值投资、精选龙头个股 —— 基金经理研究系列之九",
                "features": {
                    "keywords": [
                        "光大金工",
                        "华夏基金",
                        "蔡向阳",
                        "价值投资",
                        "龙头个股"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "基金"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "高瓴资本爱尔眼科齐“氪金” 兆科眼科上市后“光环”能否继续？",
                "features": {
                    "keywords": [
                        "高瓴资本",
                        "爱尔眼科",
                        "兆科眼科",
                        "上市",
                        "光环"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "陆港通每周复盘 | 南下资金爆买腾讯近120亿！接连两周抛售中国移动",
                "features": {
                    "keywords": [
                        "陆港通",
                        "南下资金",
                        "腾讯",
                        "中国移动"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "科技",
                        "通信"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "国金证券：爱尔眼科(300015.SZ)推出激励方案，维持“买入”评级",
                "features": {
                    "keywords": [
                        "国金证券",
                        "爱尔眼科",
                        "激励方案",
                        "买入评级"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "民营医院概念股近三日最受主力资金青睐",
                "features": {
                    "keywords": [
                        "民营医院",
                        "主力资金"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "“现象级”基金经理王宗合的2020年报都披露了啥？",
                "features": {
                    "keywords": [
                        "基金经理",
                        "王宗合",
                        "年报"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "基金"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "湖南区域股市周报：总市值涨574亿景峰医药涨幅排第一",
                "features": {
                    "keywords": [
                        "湖南区域",
                        "股市周报",
                        "总市值",
                        "景峰医药"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "爱尔眼科发布“超强”股权激励计划 首次拟授予人数高达4909人",
                "features": {
                    "keywords": [
                        "爱尔眼科",
                        "股权激励",
                        "超强"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "中泰证券维持爱尔眼科买入评级：再推股权激励，兼具广度深度",
                "features": {
                    "keywords": [
                        "中泰证券",
                        "爱尔眼科",
                        "买入评级",
                        "股权激励"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【银河医药孟令伟/刘晖】行业动态 2021.3丨一季度疫苗批签发：重磅品种保持快速增长",
                "features": {
                    "keywords": [
                        "银河医药",
                        "疫苗",
                        "批签发",
                        "重磅品种"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "方正深度严选 | 医药·天宇股份深度：沙坦类原料药龙头，新业务新项目助力高成长（47页）",
                "features": {
                    "keywords": [
                        "方正深度",
                        "天宇股份",
                        "沙坦类原料药",
                        "龙头",
                        "高成长"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}